Chromosomal localization, gene structure, and expression pattern of DDAH1: comparison with DDAH2 and implications for evolutionary origins.
about
S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolaseGenetics and visceral leishmaniasis: of mice and manAsymmetric dimethyarginine as marker and mediator in ischemic strokeInhibitors of the Hydrolytic Enzyme Dimethylarginine Dimethylaminohydrolase (DDAH): Discovery, Synthesis and DevelopmentDimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginineFarnesoid X receptor agonist reduces serum asymmetric dimethylarginine levels through hepatic dimethylarginine dimethylaminohydrolase-1 gene regulationStructural and functional characterization of the Zn(II) site in dimethylargininase-1 (DDAH-1) from bovine brain. Zn(II) release activates DDAH-1.Sequence variation in DDAH1 and DDAH2 genes is strongly and additively associated with serum ADMA concentrations in individuals with type 2 diabetes.Vascular endothelial-specific dimethylarginine dimethylaminohydrolase-1-deficient mice reveal that vascular endothelium plays an important role in removing asymmetric dimethylarginine.Regulation of the ADMA-DDAH system in endothelial cells: a novel mechanism for the sterol response element binding proteins, SREBP1c and -2.Hypermethylation of DDAH2 promoter contributes to the dysfunction of endothelial progenitor cells in coronary artery disease patientsCerebral changes occurring in arginase and dimethylarginine dimethylaminohydrolase (DDAH) in a rat model of sleeping sicknessMechanisms of nitric oxide synthase uncoupling in endotoxin-induced acute lung injury: role of asymmetric dimethylarginine.Active site mutant dimethylarginine dimethylaminohydrolase 1 expression confers an intermediate tumour phenotype in C6 gliomas.Toxicity of ochratoxin a and its modulation by antioxidants: a review.Discovery of structurally-diverse inhibitor scaffolds by high-throughput screening of a fragment library with dimethylarginine dimethylaminohydrolase.Dimethylarginine dimethylaminohydrolase 1 modulates endothelial cell growth through nitric oxide and AktNitric oxide and reactive nitrogen oxide species in plants.Endogenous nitric-oxide synthase inhibitor ADMA after acute brain injuryCa(2+)-activated chloride channels go molecular.Dimethylarginine dimethylaminohydrolase/nitric oxide synthase pathway in liver and kidney: protective effect of cyanidin 3-O-β-D-glucoside on ochratoxin-A toxicityPharmacotherapies and their influence on asymmetric dimethylargine (ADMA).ADMA metabolism and clearance.How to control NO production in cells: N(omega),N(omega)-dimethyl-L-arginine dimethylaminohydrolase as a novel drug target.Arginine, arginine analogs and nitric oxide production in chronic kidney disease.Dimethylarginine dimethylaminohydrolase 1 is involved in spinal nociceptive plasticity.Dimethylarginine dimethylaminohydrolase 2 promotes tumor angiogenesis in lung adenocarcinoma.Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia.Asymmetric dimethylarginine (ADMA)--a modulator of nociception in opiate tolerance and addiction?Nitric oxide deficiency in chronic kidney disease.Regulation of DDAH1 as a Potential Therapeutic Target for Treating Cardiovascular Diseases.Effect of asymmetric dimethylarginine (ADMA) on heart failure development.Dimethylarginine Dimethylaminohydrolase 2 (DDAH 2) Gene Polymorphism, Asymmetric Dimethylarginine (ADMA) Concentrations, and Risk of Coronary Artery Disease: A Case-Control Study.The prominent role of the liver in the elimination of asymmetric dimethylarginine (ADMA) and the consequences of impaired hepatic function.Overexpression of dimethylarginine dimethylaminohydrolase 1 attenuates airway inflammation in a mouse model of asthmaEndogenous nitric oxide synthase inhibitors in the biology of disease: markers, mediators, and regulators?Asymmetric Dimethylarginine and Hepatic Encephalopathy: Cause, Effect or Association?Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA).The role of asymmetric and symmetric dimethylarginines in renal disease.Role of asymmetrical dimethylarginine in the progression of renal disease.
P2860
Q24536087-81478AE3-8C29-40C4-A57C-D776DCF3407AQ24612701-5016F9EA-7808-470D-A8A6-26BAEDD240BEQ26864318-CBD03462-BDC1-4CCC-80DB-FE61E8545A21Q28070134-E8D8A56F-FCC3-4A19-80A7-323FC2A18004Q28506246-1540C047-1DA4-415C-8D93-EA81C2637DE2Q28581627-AF0D3F49-EE7F-4A0A-91A4-0B042F554AB8Q30328626-319A3131-01E8-4BEB-AE93-289750B87A20Q33538038-3313ED05-4A80-4386-B6DC-1B137F3E792BQ33582151-CA1D1B43-B800-406F-AE9D-2684E46CFA9FQ33589158-3EB0926F-5460-4A1C-B10E-56160BBD6E10Q33800362-C3107F2A-73E1-43B2-9261-52E63B9620BFQ33847194-89A335A5-87AB-4D95-A575-40585653AB08Q33889586-D6C68F61-70E3-4F35-A431-75FC3D027C75Q33904265-2C0A2CFD-CD5E-4A98-B65D-96431B3DFFD3Q34379821-77661328-4801-48D4-B0EA-A7705EBF39F4Q34393366-98EBE2C8-85FA-48E5-BA11-800B0E0B6769Q34721519-A14D8163-9883-4F26-901A-C5FF4658EED2Q35042505-1E3304F3-DEED-4A70-9675-9299A5790762Q35129159-063FB3E6-44C9-4677-A80D-84A37AEA3F8CQ35722982-9853BE46-BE76-4B2F-91D1-526A867D8208Q36067743-2AC3002D-B721-4933-A2FB-1117CABF87CFQ36381009-EAE01159-0F82-482A-9125-A1C557170C85Q36381017-BE138FBF-681D-4FEE-AF34-49A8DA4CEB2CQ36471209-D221AD59-1AE1-4AA3-A0B1-46C5CBBF9773Q36577145-D840074E-98B4-4386-8748-1C834C043FF6Q36628314-B6E39D89-94C4-49CE-8C8E-6B0C177F323FQ36651307-494399EA-3841-4EF5-9B2B-D46E8780B284Q36844696-A47FCD53-7BD6-4706-B4EC-25D35365BCB4Q36878181-8DC35E94-6C06-4C4D-A60A-A11783B1440DQ36967585-2082C009-9826-4BDC-A479-2630A9BFE146Q37009925-3CC30472-2F37-4CAE-99F7-75C689C7A2A6Q37245523-4F71D7B9-2A4D-4EB3-9F45-EC5F45ACEA7FQ37290635-9E05F7F9-FFF9-4D51-BF26-60637C744CA0Q37313734-ACB728C4-C346-4AD2-946B-B137DA3404FBQ37490288-18BF4DE9-DA61-4D43-9EB0-BBDFDAA48909Q37684919-2BC45CD4-8FD5-4413-90F7-FAD3352D9755Q37710176-DFF57889-17D2-4432-8B20-689FBDE9C2ACQ37727924-790B1FBF-CE9D-4E46-884A-79729A6F7F5CQ37858880-C532CF0F-D667-4E3C-A050-02D60E5D9919Q38046935-016F8E07-76FE-415A-B92F-71129BAC7485
P2860
Chromosomal localization, gene structure, and expression pattern of DDAH1: comparison with DDAH2 and implications for evolutionary origins.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Chromosomal localization, gene ...... ions for evolutionary origins.
@en
Chromosomal localization, gene ...... ions for evolutionary origins.
@nl
type
label
Chromosomal localization, gene ...... ions for evolutionary origins.
@en
Chromosomal localization, gene ...... ions for evolutionary origins.
@nl
prefLabel
Chromosomal localization, gene ...... ions for evolutionary origins.
@en
Chromosomal localization, gene ...... ions for evolutionary origins.
@nl
P2093
P356
P1433
P1476
Chromosomal localization, gene ...... ions for evolutionary origins.
@en
P2093
P304
P356
10.1006/GENO.2000.6262
P577
2000-08-01T00:00:00Z